Department of Psychiatry
Research & Publications
- Recent Publications by Department of Neuropsychiatry Faculty and Residents
1. Wilcox, James Allen, Gazarov, Aleksandr. Book Forum: Psychotic Disorders: Catatonia: From Psychopathology to Neurobiology. Am J Psychiatry 162:1987-a-1988, October 2005.
2. Briones, David F., Wilcox, James A., Mateus, Beatriz A., Boudjenah, Djillali. Risk Factors and Prevention in Adolescent Substance Abuse: A Biopsychosocial Approach. IN PRESS: Adolescent Medicine Clinics, 2005.
3. Heller, Peter L., Briones, David F., Schiffer, Randolph B., Guerrero, Martin, Royall, Donald R., Wilcox, James A., Ledger, Elizabeth M. Mexican-American Ethnicity and Cognitive Function: Findings from an Elderly Southwestern Sample. IN PRESS: Journal of Neuropsychiatry and Behavioral Science, 2005.
4. Wilcox, J.A., Book Review: Treatment Matching in Alcoholism. American Journal of Psychiatry, August 2004; 161:1514.
5. Guerrero, Martin and Heller, Peter L. Cultural Limits in Informed Consent with Dementia Research. Alzheimer Disease and Associated Disorders, April-June, 17, 2003, Supplement 1, S26-30.
6. Wilcox, J.A., Book Review: Neurochemistry of Consciousness: Neurotransmitters in Mind. American Journal of Psychiatry, October 2003; 160: 1896a-97.
7. Giordano, Frank L., Briones, David F. Assessing Residents' Competence in Psychotherapy. Academic Psychiatry, 27:3, Fall 2003, 145-7.
8. Wilcox, J.A., Tsuang M.T., Schnurr, T., Baida-Fragoso, N. Case-control family study of lesser variant traits in autism. Neuropsychobiology, 2003; 47(4): 171-7.
9. Briones, David F., Heller, Peter L., Guerrero, Martin , Schiffer, Randolph B., Wilcox, James A., Ledger, Elizabeth M., Cutter, Minerva L. Cultural vs. Educational Bias in Three Widely-Used Cognitive Screening Instruments Among Elderly Mexican-American and Non-Hispanic White Residents of El Paso County , Texas . Texas/World Health Organization Collaborating Center Proceedings of the Annual Meetings on Cross-Cultural Research and Training on Mental Health and Psychosocial Factors in Health in Mexico and Texas , Spring 2002.
10. Wilcox, J.A. Book Review: Schizophrenia Revealed: From Neurons to Social Interactions. American Journal of Psychiatry, August 2002; 159: 1450-51.
11. Briones, David F. Book Review: Bipolar Disorders, Clinical Course and Outcome. Journal of Depressive Disorders, Fall 2002.
12. Giordano, Frank L. Book Review: How to Effectively Organize Your Interview, Oral Presentation, and Video Exam. In press, Soar Dime Limited, Fall 2002.
13. Briones, David F., Ramirez, Arthur L., Guerrero, Martin and Ledger, Elizabeth . Determining Cultural and Psychosocial Factors in Alzheimer Disease Among Hispanic Populations. Alzheimer Disease and Associated Disorders, 16 Supplement 2:S86-8, 2002.
14. Wilcox, J., Tsuang, M., Ledger, E., Algeo, J., Schnurr, T. Brain Perfusion in Autism Varies with Age. Neuropsychobiology, 46:13-16, 2002.
15. Wilcox, J. Book Review: Schizophrenia in Children and Adolescents. American Journal of Psychiatry, 159:4, p. 685, 2002.
16. Wilcox, J.A., Ramirez, A.L. Book Review: Handbook of Substance Abuse: Neurobehavioral Pharmacology. American Journal of Psychiatry; April 2001, 158: 669.
17. Wilcox, James and Guerrero, Martin. Bipolar Disorder, the Economics of Treatment. Annals of Clinical Psychiatry, vol. 13, no.1: 60-61, 2001.
18. Wilcox, James and Baida-Fragoso, Nicolas. Impulse Reduction and Suicide Prevention, Annals of Clinical Psychiatry, vol. 13, no.1: 59-60, 2001.
19. Wilcox, J.A. Book Review: Clinical Textbook of Addictive Disorders, 2 nd edition. American Journal of Psychiatry, August 1999; 156: 1287-88.
20. Neuman, Mark, and Wilcox, James Depression: The Diagnostic Enigma. The El Paso Physician, September 1999.
- DEPARTMENT OF NEUROPSYCHIATRY ACTIVE RESEARCH PROJECTS
1. The Study of Olanzapine plus Fluoxetine in Combination for Treatment-resistant Depression without Psychotic Features, David F. Briones, M.D., Eli Lilly and Company, $256,423.
2 . An International, Multicenter Large Simple Trial (LST) to Compare the Cardiovascular Safety of Ziprasidone and Olanzapine, Martin Guerrero, M.D., Pfizer , $6000.
3. Alzheimer's Disease in El Paso 's Residential Elderly Population, Martin Guerrero, M.D., Center for Border Health Research, $75,000.
4. A Mastery-Based Weight Prevention Program for the Management of Antipsychotic-Related Weight Gain Among Mexican-American Patients: A Pilot Project, David F. Briones, M.D., Eli Lilly and Company, $73,250.
5. An Olanzapine Model for Relieving Anxiety in Schizophrenic Patients and Implications for Enhanced Compliance, Arthur L. Ramirez, M.D., Eli Lilly and Company, $24,648.
6. A Randomized Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia, Martin Guerrero, M.D., Eli Lilly and Company.
7. A Neurogenetic Investigation of Patients with Schizophrenia Spectrum Disorders and Participating Family Members, James A. Wilcox, D.O., Ph.D., National Institute of Mental Health.
8. Surveillance for Multiple Sclerosis and Amyotrophic Lateral Sclerosis in Texas, Richard Brower, M.D., Texas Department of Health.
Department of Neuropsychiatry Completed Research Projects
1. Olanzapine versus Ziprasidone in the Treatment of Schizophrenia , James A. Wilcox, D.O., Eli Lilly and Company, $177,415 .
2. A Controlled Trial of Olanzapine versus Ziprasidone in the Treatment of Schizophrenic and Schizoaffective Subjects with Comorbid Depression , Martin Guerrero, M.D., Eli Lilly and Company , $135,026 .
3. A Comparison of Fasting Triglyceride Levels in Cohorts with Schizophrenia and Related Disorders Treated Chronically with Olanzapine, Risperidone, and Typical Antipsychotics, David F. Briones, M.D., Eli Lilly and Company, $30,917.
4. A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Evaluation of Lamotrigine Adjunctive Therapy in Subjects with Primary Generalized Tonic-clonic Seizures, Richard D. Brower, M.D., GlaxoSmithKline.
5. Lilly F1D-MC-HGHZ The combination of olanzapine and fluoxetine in treatment-resistant depression without psychotic features .
6. Lilly F1D-MC-HGJX A comparison of fasting triglyceride levels in cohorts with schizophrenia and related disorders treated chronically with olanzapine, risperidone and typical antipsychotics .
7. Lilly F1D-US-HGJU A controlled trial of olanzapine versus ziprasidone in the treatment of schizophrenic and schizoaffective subjects with comorbid depression.
8. Lilly F1D-MC-HGHJ Olanzapine versus ziprasidone in the treatment of schizophrenia.
9. Lilly F1D-MC-HGGY Placebo-controlled monotherapy in the treatment of bipolar I depression.
10. Center for Border Health Research Psychological distress among elderly Hispanic and Anglo residents of El Paso , Texas .